MLAB 2401: C LINICAL C HEMISTRY K ERI B ROPHY -M ARTINEZ Point of Care Testing 1.

Slides:



Advertisements
Similar presentations
FDA QS reg/CLIA Comparison: Overview
Advertisements

TJC – POCT “In Toto” Judy Gabriel, MT(ASCP) BS, MA
PinnacleHealth System
Point of Care Competency Testing at Lancaster General Hospital
CAP/POCT 2003 Carol Riley-Hunte, RRT Senior Education Specialist Bayer HealthCare.
Point of Care Testing BOPCC May 31, 2011 Beatrice OKeefe, Chief Laboratory Field Services California Department of Public Health.
Bay Area POCC Spring Meeting Stanford University Medical Center
P OINT OF CARE TESTING Lecture 6. D EFINITION Medical testing at or near the site of patient care. It is a mode of analysis which is performed at the.
QUALITY CONTROL IN HEMATOLOGY
JOURNAL REPORT Hernandez Jay, Hernandez L, Ishimura M, Pascua R.
The Joint Commission Chapter update: Waived Testing
Standard 22B Instructional Areas HT Accredited Curriculum.
MLAB 2401: C LINICAL C HEMISTRY K ERI B ROPHY -M ARTINEZ Designs in Instrumentation Electrochemistry.
1 FDA/CDRH PUBLIC MEETING; Blood Glucose Meters FDA/CDRH PUBLIC MEETING; Blood Glucose Meters FDA Perspective: Regulatory Challenges for Safe use of Blood.
CLIA Waived Testing for Physician Office Labs Doris Thompson, Ph.D., MT (ASCP) AK State Public Health Laboratories State CLIA Program Francisca Lehr, M.S.,
© Wipfli LLP 1 Date or subtitle © Wipfli LLP Jeff Bramschreiber, CPA, Partner Wipfli Health Care Practice Iowa Association of Rural Health Clinics RHC.
1 Quality System Considerations for Over-The-Counter HIV Testing Devery Howerton, Ph.D. Chief, Laboratory Practice Evaluation and Genomics Branch, Division.
Good laboratory practices with waived test systems
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in any manner.
Laboratory Personnel Dr/Ehsan Moahmen Rizk.
Dr Samah Kotb Lecturer of Biochemistry 1 CLS 432 Dr. Samah Kotb Nasr El-deen Biochemistry Clinical practice CLS 432 Dr. Samah Kotb Nasr.
Competency/Training and CLIA
Quality Control Barbara Weberman MT(ASCP) Oakland County Health Division Laboratory Supervisor.
QUALITY ASSURANCE IN BLOOD BANKING
Module 5 Postanalytical Phase of Laboratory Testing.
The Molecular Diagnostics Research Laboratory University of Malaya Development and Implementation of a Quality System The Molecular Diagnostics Research.
Sept 13-15, 2004IHE Interoperability Workshop 1 Laboratory Technical Framework New Integration Profiles Francois Macary GWI Medica France - Agfa Healthcare.
P RINCIPLES OF C LINICAL C HEMISTRY A UTOMATION. A UTOMATION I N C LINICAL C HEMISTRY The modern clinical chemistry laboratory uses a high degree of automation.
QUALITY ASSURANCE Shree Baboolal 12 th February, 2005.
CLIA COMPLIANCE. What is CLIA? In 1988 Congress turned its attention to deficiencies in the quality of services provided by the nation’s laboratories.
Call-In Information Web meeting address: Meeting number Access Code: Join the audio portion at:
© 2014 Cengage Learning. All Rights Reserved. May not be scanned, copied or duplicated, or posted to a publicly accessible website, in whole or in part.
Unit #7 - Basic Quality Control for the Clinical Laboratory
WWLC Standard Operating Procedures Presented by Frank Hall, Laboratory Certification Coordinator.
Virtua Medical Group.
THROUGH PROFICIENCY TESTING
Performance Improvement in Microbiology Laboratory
IIIIIIIIIIIIIIIIII Point of care testing (POCT) Dr K.A.C.Wickramaratne.
Unit 8 Presentation Chapter 17
CAP Accreditation of Genetics Testing Laboratories Genetic Alliance May 16, 2007 Gail Vance, MD, FCAP College of American Pathologists.
Medical Laboratory Diagnostic Services Careers. Medical Lab Careers Medical Lab careers include: Phlebotomy technician Phlebotomy technician Medical laboratory.
Bashir Farah 1*, Pole Lewa 1, Bernard Omondi 1, Omu Anzala 1 1 KAVI-Institute of Clinical Research (ICR), University of Nairobi, Assessment of the Temperature.
CLIA Final Regulation Judy Yost Director, Division of Laboratory Services CMS.
MLAB 2401: Clinical Chemistry Keri Brophy-Martinez
Introduction to the Clinical Laboratory
Who makes up all these rules?? A discussion on Regulatory Agencies and how they relate to each other and our lab.
Principles of Clinical Chemistry Automation
Michigan Regional Laboratory System Reorganization Frances Pouch Downes, Dr.P.H. Jeffrey P. Massey, Dr.P.H. MDCH Bureau of Laboratories.
CLIA Hot Topics CLIA Gary Yamamoto
Biochemistry Clinical practice CLS 432 Dr. Samah Kotb Lecturer of Biochemistry 2015 Introduction to Quality Control.
UPCOMING CHANGES TO IN-VITRO DIAGNOSTICS (IVDs) AND LABORATORY DEVELOPED TESTS (LDTs) REGULATIONS Moj Eram, PhD November 5, 2015.
GTP Scenario # 6 September 17,2005. Scenario # 6 The Institute of America collects, processes and transplants PBPC. The Institute of America collects,
Point of Care Testing - CLSI. Quality practices for better health. Our Vision Free Wind 2014 / Shutterstock.com.
Introduction to Quality Assurance. Quality assurance vs. Quality control.
A LOOK AT AMENDMENTS TO ISO/IEC (1999) Presented at NCSLI Conference Washington DC August 11, 2005 by Roxanne Robinson.
Quality Assurance.
Unit #6 - Basic Quality Control for the Clinical Laboratory
Overview of Quality Assurance
Quality Assurance in the clinical laboratory
Clinical Engineering Lecture (3).
Point of Care Testing California Clinical Laboratory Association
Complying With CLIA Competency Requirements
CLIA Hot Topics CLIA Gary Yamamoto
Quality System Considerations for Over-The-Counter HIV Testing
Quality Assurance Documentation
CPT Pathology and Laboratory
Safety and Regulatory Guidelines In the Medical Laboratory
Quality Control Barbara Weberman MT(ASCP)
Point of Care 101.
Research Operations and Lab Services
Presentation transcript:

MLAB 2401: C LINICAL C HEMISTRY K ERI B ROPHY -M ARTINEZ Point of Care Testing 1

P OINT OF C ARE T ESTING Analytical patient - testing activities provided within the institution, but performed outside the physical facilities of the clinical laboratories Alternative names Bedside testing Ancillary testing Off-site testing Waived testing 2

P OINT OF C ARE T ESTING CLIA 88 In 1988, Congress passed the Clinical Laboratory Improvement Act. Regulations were not written until 1990, comments were added, and changes were made. Implementation was September 1, Overseen by the FDA and CMS 3

P OINT OF C ARE T ESTING Types of Classified laboratories Those performing waived tests only Those performing moderate complex testing Has allowance for “PPMP”: provider performed microscopy procedures Those performing highly complex tests. Classification based on difficulty or complexity of test procedures and level of training required to accurately perform the test. Laboratory standards differ for each of the categories. 4

P OINT OF C ARE T ESTING Waived – Lab must have CLIA waiver certificate No certification requirements of those performing the test No proficiency testing No minimum training for testing personnel Criteria of a waived test: if the results of the test are in error, no immediate danger exists for the patient. 5

P OINT OF C ARE T ESTING Examples of waived tests several methods for hemoglobin determination blood glucose by meters approved for home use Hb A1c fecal occult blood spun hematocrit ovulation tests(by color comparison) urine pregnancy tests urine dipstick esr PT immunoassay for mononucleosis FDA’s website for waived testing FDA’s website 6

P OINT OF C ARE T ESTING Moderately Complex Testing Lab must have Certificate of Accreditation Includes many manual procedures with limited steps and preparation OR automated analyses that do not require operator intervention during the analytical process. Requires Proficiency testing. Responsible person ( oversight structure) for the technical and scientific oversight of the testing. Personnel have specific training and orientation to perform the test. Continuing competency must be documented. Minimum high school diploma Lab must have lab director / technical consultant. 7

P OINT OF C ARE T ESTING Highly complex testing Lab must have Certificate of Accreditation Must meet all criteria of moderately complex testing lab Personnel must have minimum Associate Degree or equivalent. Like the moderate complex level, Lab must have lab director / technical consultant. 8

P OINT OF C ARE T ESTING Highly complex testing Testing can include procedures Requiring considerable decision making, complex judgment & analysis of results to provide interpretation. Specialized scientific and technical knowledge required. Test may require special preparation of reagents, extensive technical and quality control measures 9

P OINT OF C ARE T ESTING Most hospitals perform moderate to highly complex testing and must: follow hiring guidelines participate in proficiency testing maintain comprehensive record keeping have established quality assurance programs and are subject to government inspections 10

P OINT OF C ARE T ESTING Proficiency Testing (PT) PT is mandated by CLIA for all labs performing moderate or high complexity testing as a method for evaluating performance quality by an external agency. Process Labs are provided with samples of analyte; values are known only to the testing program. The lab analyzes the specimens in the same manner as patient specimens. If a lab fails in a particular analyte, it will have a chance to reanalyze other specimens to prove its quality performance; if it fails in that area again, there is a possibility it will not be approved reimbursement from Medicare or Medicaid for that analyte. 11

P OINT OF C ARE T ESTING : A DVANTAGES Fast delivery of results Small sample volume Overall low cost Portable 12

P OINT OF C ARE T ESTING : D ISADVANTAGES Quality of results Management and documentation issues 13

P OINT OF C ARE T ESTING A PPLICATIONS Glucose Highest volume Likely the first application of POCT (home testing) Instruments become very sophisticated and many maintain log of QC results. Chemistries and Blood Gases Coagulation testing Activated clotting time - for monitoring heparin therapy Hematology Spun hematocrit - can have several opportunities for error, therefore being replaced by hemoglobin measurement 14

P OINT OF C ARE T ESTING POC Connectivity To eliminate error due to transcription of results; most instruments now capable of electronically sending test data Most significant recent development in POCT Three components of connectivity: Device: Instrument itself can store data. Data management: Instrument uploads data to work station. Interface: Data manager transmits test results to information system. 15

R EFERENCES Bishop, M., Fody, E., & Schoeff, l. (2010). Clinical Chemistry: Techniques, principles, Correlations. Baltimore: Wolters Kluwer Lippincott Williams & Wilkins. cfClia/testswaived.cfm?start_search=C